Clinical Trials in Illinois

Showing 13141-13160 of 19,692 trials

BÜHLMANN fCAL™ ELISA - Aid in Differentiation of IBD From IBS

NCT02351635

The purpose of this study is to confirm the sensitivity and specificity of the BÜHLMANN fCAL™ ELISA as an aid in diagnosis to differentiate between Inflammatory Bowel Disease (IBD; Crohn's Disease (CD), Ulcerative Colitis (UC), or indeterminate colitis) and Irritable Bowel Syndrome (IBS). To estimate the predictive value of a positive test (positive predictive value (PPV)) and the predictive value of a negative test (Negative Predictive Value (NPV)) using the proposed test outcomes for BÜHLMANN Calprotectin Test results when used in patients referred for diagnostic evaluation with signs and symptoms suggestive of either IBS or IBD. To confirm the inter-laboratory consistency of test results for the BÜHLMANN fCAL™ ELISA. To provide exploratory observations of test results in patients between the age of 2 and 21 years. To provide a sample set from normal subjects with no symptoms or signs of gastrointestinal disease for use in Expected Value Testing.

Inflammatory Bowel DiseaseIrritable Bowel Syndrome

Bühlmann Laboratories AG478 participantsStarted Jan 2015

Palo Alto, California, United States • Miami, Florida, United States • Macon, Georgia, United States +4 more locations

TERMINATEDPhase 2112 miles

GRN1005 in Non-Small Cell Lung Cancer (NSCLC) Patients With Brain Metastases (GRABM-L)

NCT01497665

The purpose of this study is to assess the efficacy, safety, and tolerability of GRN1005 in patients with brain metastases from non-small cell lung cancer (NSCLC).

Non-small Cell Lung Cancer (NSCLC) With Brain Metastases

Angiochem Inc16 participantsStarted Nov 2011

La Jolla, California, United States • Aurora, Colorado, United States • Tampa, Florida, United States +7 more locations

BÜHLMANN fCAL™ ELISA - Aid in Differentiation of IBD From IBS

GRN1005 in Non-Small Cell Lung Cancer (NSCLC) Patients With Brain Metastases (GRABM-L)

Find Trials by Condition in Illinois

A Study to Evaluate Pharmacokinetics, Safety and Efficacy of Albiglutide in Pediatric Subjects With Type 2 Diabetes Mellitus

Early Access Treatment With Daratumumab for (Relapsed or Refractory) Multiple Myeloma

Baminercept, a Lymphotoxin-Beta Receptor Fusion Protein, for Treatment of Sjögren's Syndrome

A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD

PRospective Study to Evaluate EffectivenesS With the NURO™ PErcutaneous Tibial Neuromodulation System in Patients With OAB

Study To Evaluate the Efficacy and Safety Of Bevacizumab, and Associated Biomarkers, In Combination With Paclitaxel Compared With Paclitaxel Plus Placebo as First-line Treatment Of Patients With Her2-Negative Metastatic Breast Cancer

A Study of Safety and Efficacy of BTD-001 in Treatment of Patients With Idiopathic Hypersomnia (IH) or Narcolepsy Type 2

Study of the Effects of Brilacidin Oral Rinse on Radiation-induced Oral Mucositis in Patients With Head and Neck Cancer

Bronchodilator Effects and Safety of Glycopyrronium Bromide (25 ug and 50 ug o.d.) in Asthma

Omadacycline vs Moxifloxacin for the Treatment of CABP (EudraCT #2013-004071-13)

Single-Agent Glasdegib In Patients With Myelofibrosis Previously Treated With Ruxolitinib

Pragmatic Airway Resuscitation Trial

Study Evaluating Prophylaxis Treatment & Characterizing Efficacy, Safety, & PK Of B-Domain Deleted Recombinant FVIII

A Study of LY2090314 and Chemotherapy in Participants With Metastatic Pancreatic Cancer

Early Family-Centered Prevention of Drug Use Risk (Aka Early Steps)

Detection of Cytomegalovirus Virus in Neonates

Stereotactic Body Radiation Therapy in Treating Patients With Inoperable Stage I or Stage II Non-Small Cell Lung Cancer

Proton Radiotherapy for Patients With Non-Small Cell Lung Cancer (NSCLC)